Researchers have found that new myelin-making cells are constantly being made in the brain and spinal cord, even in the ...

A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease progression that could help identify patients most likely to benefit from new drugs.

Multiple sclerosis (MS) is primarily recognised as a chronic demyelinating disease of the central nervous system, yet its impact extends to the autonomic nervous system (ANS), which governs vital ...

Foralumab stabilized disability for 6 months in all 10 people with nonactive SPMS who took part in an expanded access program, a study found.

Scientists have long suspected that industrial pollutants might help trigger multiple sclerosis, but the latest evidence ...

May 30, 2025, is the 17 th annual World Multiple Sclerosis Day, a day when the global medical community focuses on those living with Multiple Sclerosis (MS), a complex and frequently misunderstood ...

The earliest symptoms of multiple sclerosis (MS) can come and go, which makes them easy to ignore — and makes diagnosing this common neurological disease complicated. That’s why it’s so important to ...

Silent cells deep in your spinal cord may hold a surprising key to healing after devastating injuries and brain disease. A ...

Both Guillain-Barré syndrome and multiple sclerosis involve an autoimmune attack on the nervous system. Guillain-Barré syndrome affects the peripheral nervous system, while multiple sclerosis impacts ...

Neurologists warn many people dismiss early signs of nervous system problems, risking delayed diagnosis. Symptoms such as ...

Autoimmune diseases such as multiple sclerosis arise when the immune system turns against the body itself. Yet for most of them, it remains unclear why this process begins. Researchers have now ...